miR-21 Expression Determines the Early Vaccine Immunity Induced by LdCen -/- Immunization

No vaccine exists against visceral leishmaniasis. Toward developing vaccines against VL, we have reported previously on the immunogenicity of live attenuated parasites in animal models. Immunization with parasites has been shown to induce durable protective immunity in pre-clinical animal models. Al...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology Vol. 10; p. 2273
Main Authors: Gannavaram, Sreenivas, Bhattacharya, Parna, Siddiqui, Abid, Ismail, Nevien, Madhavan, Subha, Nakhasi, Hira L
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 24-09-2019
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:No vaccine exists against visceral leishmaniasis. Toward developing vaccines against VL, we have reported previously on the immunogenicity of live attenuated parasites in animal models. Immunization with parasites has been shown to induce durable protective immunity in pre-clinical animal models. Although the innate immune responses favoring a Th1 type immunity are produced following immunization, the molecular determinants of such responses remain unknown. To identify early biomarkers of immunogenicity associated with live attenuated parasitic vaccines, we infected macrophages derived from healthy human blood donors with or parasites and compared the early gene expression profiles. In addition to altered expression of immune related genes, we identified several microRNAs that regulate important cytokine genes, significantly altered in infection compared to infection. Importantly, we found that infection suppresses the expression of microRNA-21 (miR-21) in human macrophages, which negatively regulates IL12, compared to infection. In murine DC experiments, infection showed a reduced miR-21 expression with a concomitant induction of IL12. Silencing of miR-21 using specific inhibitors resulted in an augmented induction of IL12 in infected BMDCs, illustrating the role of miR-21 in mediated suppression of IL12. Further, exosomes isolated from infected DCs contained significantly reduced levels of miR-21 compared to infection, that promoted proliferation of CD4 T cells . Similar miR-21 mediated IL12 regulation was also observed in human macrophage infection experiments indicating that miR-21 plays a role in early IL12 mediated immunity. Our studies demonstrate that infection suppresses miR-21 expression, enables IL12 mediated induction of adaptive immunity including proliferation of antigen experienced CD4 T cells and development of a Th1 immunity, and suggest that miR-21 could be an important biomarker for vaccine immunity in human clinical trials. Role of miR-21 in vaccine induced immunity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Nahid Ali, Indian Institute of Chemical Biology (CSIR), India
Reviewed by: Maria Agallou, Pasteur Hellenic Institute, Greece; Sima Rafati, Pasteur Institute of Iran (PII), Iran
These authors have contributed equally to this work
This article was submitted to Vaccines and Molecular Therapeutics, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2019.02273